CHUM

Running trials

• Not yet recruiting

  Outside the Cage (OTC) Robotic Esophagectomy

  NCT06735638· Phase 1· Source

• Not yet recruiting

  Dialysis Less Frequently in the Elderly

  NCT07738731· Source

• Recruiting

  RO7771950 Versus Tucatinib in Combination With Trastuzumab and Capecitabine in People With Locally Advanced or Metastatic Breast Cancer That is Human Epidermal Growth Factor Receptor 2 (HER2)-Positive

  NCT07413939· Phase 2/3· Source

• Recruiting

  A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease

  NCT07174310· Phase 3· Source

• Recruiting

  A Portable Thoracic Impedance Device for Detecting Pulmonary Congestion in Heart Failure Patients

  NCT06604468· Source

• Recruiting

  Study of Neoadjuvant Cemiplimab and Dupilumab in Early-Stage Non-Small Cell Lung Cancer

  NCT06743581· Source

• Recruiting

  Safety and Efficacy of OD-07656 and of Subsequent Vedolizumab Therapy in Moderately to Severely Active Ulcerative Colitis

  NCT06850727· Phase 2· Source

• Active, not recruiting

  EF-41/KEYNOTE D58: Phase 3 Study of Optune Concomitant With Temozolomide Plus Pembrolizumab in Newly Diagnosed Glioblastoma

  NCT06556563· Phase 3· Source

• Recruiting

  Glycemic Control and Osteohealth in Adults Living With Type 1 Diabetes

  NCT06158503· Source

• Recruiting

  Clinical Utility of a Genomic Predictor Test on the Management of Cardiorenal Complications of Type 2 Diabetes

  NCT06586203· Source

• Recruiting

  LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLC

  NCT06216301· Phase 3· Source

• Active, not recruiting

  A Study to Learn About the Effectiveness of Etrasimod in People With Ulcerative Colitis

  NCT06294925· Source

• Active, not recruiting

  Repetitive Versus Deep Transcranial Magnetic Stimulation for Major Depression

  NCT05902312· Source

• Active, not recruiting

  Outside the Cage (OTC) Robotic Lobectomy

  NCT05832112· Source

• Active, not recruiting

  Combination of Olaparib and Navitoclax in Women with HGSC and TNBC

  NCT05358639· Phase 1· Source

• Active, not recruiting

  Symptomatic Carotid Outcomes Registry

  NCT05300737· Source

• Recruiting

  Efficacy of the COronary SInus Reducer in Patients With Refractory Angina II

  NCT05102019· Source

• Active, not recruiting

  Cholesterol Disruption in Combination With the Standard of Care in Patients With Advanced Pancreatic Adenocarcinoma

  NCT04862260· Early phase 1· Source

• Active, not recruiting

  Firehawk Rapamycin Target Eluting Coronary Stent North American Trial

  NCT04562532· Source

• Active, not recruiting

  PSMA PET/CT Guided Intensification of Therapy in Patients at Risk of Advanced Prostate Cancer

  NCT04557501· Phase 3· Source

• Active, not recruiting

  Amplatzer Amulet LAAO vs. NOAC

  NCT04226547· Source

• Recruiting

  Pragmatic Randomised Trial of High Or Standard PHosphAte Targets in End-stage Kidney Disease (PHOSPHATE)

  NCT03573089· Source

• Active, not recruiting

  SyncAV Post-Market Trial

  NCT04100148· Source

• Active, not recruiting

  Preservation of Swallowing in Respected Oral Cavity Squamous Cell Carcinoma: Examining Radiation Volume Effects (PRESERVE): A Randomized Trial

  NCT03997643· Phase 2· Source

• Active, not recruiting

  Fecal Microbial Transplantation in Combination With Immunotherapy in Melanoma Patients (MIMic)

  NCT03772899· Phase 1· Source

• Active, not recruiting

  Study of IMNN-001 (Also Known as GEN-1) With NACT for Treatment of Ovarian Cancer (OVATION 2)

  NCT03393884· Phase 1/2· Source

• Recruiting

  JoLT-Ca Sublobar Resection (SR) Versus Stereotactic Ablative Radiotherapy (SAbR) for Lung Cancer

  NCT02468024· Phase 3· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Chronic kidney disease3 recruiting
• Lung cancer3 recruiting
• Coronary artery disease1 recruiting
• Gastric and esophageal cancer1 recruiting
• Heart failure1 recruiting
• Metastatic breast cancer1 recruiting
• Parkinson disease1 recruiting
• Type 1 diabetes1 recruiting
• Type 2 diabetes1 recruiting
• Ulcerative colitis1 recruiting

Researchers

No researcher is linked here yet.

Closed trials

• Completed

  Detecting Metastases by PyL PET/CT in Subjects Starting Enzalutamide for Untreated Castration Resistant Prostate Cancer.

  NCT04655365· Phase 2· Source

• Completed

  The BURAN Study of Buparlisib in Patients With Recurrent or Metastatic HNSCC

  NCT04338399· Phase 3· Source

• Completed

  Confirm Rx Insertable Cardiac Monitor SMART Registry

  NCT03505801· Source

• Terminated

  Blinded Randomized Trial of Anticoagulation to Prevent Ischemic Stroke and Neurocognitive Impairment in AF

  NCT02387229· Phase 3· Source

• Completed

  Efficacy of Implantable Defibrillator Therapy After a Myocardial Infarction

  NCT00673842· Phase 3· Source